Benjamin Bronfman is the Co-Founder of DGH, a private equity firm focused on the global medical cannabis opportunity.  DGH operates in federally legal jurisdictions and has portfolio assets that include Bedrocan International and ICCI. Bronfman is the President of Business Development at Bedrocan International and a member of it's Board of Directors.